Essential Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$894 Sell
66
-602
-90% -$7.2K ﹤0.01% 2286
2026
Q1
$4K Sell
668
-843
-56% -$6.34K ﹤0.01% 1689
2025
Q4
$10.8K Sell
1,511
-4
-0.3% -$32 ﹤0.01% 1148
2025
Q3
$16.2K Buy
1,515
+741
+96% +$7.27K 0.01% 973
2025
Q2
$7.49K Buy
+774
New +$7.98K ﹤0.01% 934

Other funds holding OGN

Essential Partners's OGN Position: Q2 2026 in Review

Essential Partners reduced its Organon & Co (OGN) stake by 90% in Q2 2026, selling an estimated $7.2K and leaving 66 shares worth $894. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Essential Partners first reported a position in OGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $16.2K in Q3 2025. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Essential Partners held 66 shares of Organon & Co worth $894 as of Q2 2026.
  • Essential Partners sold 602 Organon & Co shares in Q2 2026, an estimated $7.2K.
  • Organon & Co made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2286 holding.
  • Essential Partners first reported a position in Organon & Co in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Organon & Co position peaked at $16.2K in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.